Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Create alerts with multiple filters including highs/low, comparative values, and turning points. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC.TO)

Bausch Health Companies Inc (BHC.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,767,223
  • Shares Outstanding, K 361,728
  • Annual Sales, $ 8,434 M
  • Annual Income, $ -948,000 K
  • 60-Month Beta 1.26
  • Price/Sales 0.26
  • Price/Cash Flow 3.30
  • Price/Book N/A
Trade BHC.TO with:

Options Overview Details

View History
  • Implied Volatility 102.47% ( +0.39%)
  • Historical Volatility 219.53%
  • IV Percentile 89%
  • IV Rank 18.52%
  • IV High 509.99% on 07/28/22
  • IV Low 9.82% on 11/25/21
  • Put/Call Vol Ratio 0.86
  • Today's Volume 108
  • Volume Avg (30-Day) 651
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 18,529
  • Open Int (30-Day) 13,721

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.33
  • Number of Estimates 4
  • High Estimate 1.44
  • Low Estimate 1.21
  • Prior Year 1.44
  • Growth Rate Est. (year over year) -7.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.10 +44.90%
on 07/28/22
12.03 -38.57%
on 07/20/22
-3.81 (-34.02%)
since 07/18/22
3-Month
5.10 +44.90%
on 07/28/22
13.35 -44.64%
on 05/20/22
-5.44 (-42.40%)
since 05/18/22
52-Week
5.10 +44.90%
on 07/28/22
37.42 -80.25%
on 09/23/21
-28.28 (-79.28%)
since 08/18/21

Most Recent Stories

More News
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the...

BHC.TO : 7.30 (-4.58%)
Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest...

BHC.TO : 7.30 (-4.58%)
Bausch Health reports US$145 million loss in the second quarter, lowers guidance

LAVAL, Que. — Bausch Health Companies Inc. reported a loss of US$145 million in its latest quarter compared with a loss of US$595 million a year earlier.

BHC.TO : 7.30 (-4.58%)
BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second-quarter 2022 financial...

BHC.TO : 7.30 (-4.58%)
Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced the U.S. District Court of...

BHC.TO : 7.30 (-4.58%)
Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter financial results on Tuesday, Aug. 9, 2022. Bausch...

BHC.TO : 7.30 (-4.58%)
Bausch + Lomb Provides Leadership Update

/CNW/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see...

BLCO.TO : 20.34 (-3.69%)
BHC.TO : 7.30 (-4.58%)
Salix Announces 2022 Gastrointestinal Health Scholars Program Winners

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest...

BHC.TO : 7.30 (-4.58%)
Bausch Health Stock: Why There are Better Opportunities Elsewhere

Bausch Health Companies (BHC) (TSE: BHC) is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology...

BHC : 5.64 (-5.05%)
BHC.TO : 7.30 (-4.58%)
Most actively traded companies on the Toronto Stock Exchange

TORONTO — Some of the most active companies traded Friday on the Toronto Stock Exchange:

AR.TO : 0.51 (unch)
ATH.TO : 2.44 (+4.72%)
BTE.TO : 6.62 (+3.76%)
TRP.TO : 64.53 (+0.80%)
CM.TO : 68.71 (+0.44%)
ARX.TO : 18.36 (+1.32%)
RCI-B.TO : 58.72 (-0.31%)
BHC.TO : 7.30 (-4.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 8.33
2nd Resistance Point 8.19
1st Resistance Point 7.92
Last Price 7.30
1st Support Level 7.51
2nd Support Level 7.37
3rd Support Level 7.10

See More

52-Week High 37.42
Fibonacci 61.8% 25.07
Fibonacci 50% 21.26
Fibonacci 38.2% 17.45
Last Price 7.30
52-Week Low 5.10

See More

Business Summary

Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45%...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar